Skip to main content

New Dementia Performance Measures: Opportunity for Public Comment

The AMA Physician Consortium For Performance Improvement has released a draft set of performance measures for persons with dementia. The draft is now open for public comments. It is likely that these performance measures will be influential. For example, I would not be surprised to see the VA implement many of these measures. The measures would benefit from comments by the GeriPal community. The multidisciplinary perspectives many of you can offer are likely to have a positive impact on the care of patients with dementia.

My initial overall impression of these performance measures is quite positive. They propose reasonable approaches that will improve the assessment and management of persons with dementia. The proposed performance measures encompass the following concerns:

Encouraging providers to stage the severity of dementia
Encouraging the use of standardized measures of cognitive assessment
Encouraging assessment of functional status
Encouraging better assessment and management of behavioral disturbances
Encouraging periodic screening for depression
Encouraging better counseling for safety concerns, including driving
Encouraging end of life counselling and advance care planning
Encouraging better caregiver education and support

In general, these measures concentrate on reasonable measures that should be part of the routine assessment and management of persons with dementia. Regular implementation of these measures would improve the quality of care of most patients and their caregivers.

My initial two suggestions for improvement are as follows:

  1. Discourage routine cancer screening in patients with dementia of moderate or worse severity. Their are two reasons for this recommendation. First, patients with dementia are much more likely to be harmed by routine screening than benefit. The lower life expectancy of advanced dementia makes it very unlikely detection and treatment of early stage cancer will improve survival. On the other hand, the potential harms of the screening test and downstream workup are accentuated in this population. Second, cancer screening in these patients is a potential red flag that raises general concerns about the quality of care. It at least suggests that the patient's care is not individualized to their needs. The provision of care that is at best not helpful, and at worst harmful makes it more likely that needed care is not being administered. See this post for more on this issue.
  2. Expand focus on end of life planning to more systematic focus on quality of life and palliation: Certainly, the focus on end of life planning is appropriate. But the performance measure needs to account for the importance of palliative management throughout the course of dementia, which can last many years. For example, there should be documentation of symptomatic distress. Many symptoms such as pain will not be directly caused by dementia, but will have a profound effect on disease management and quality of life. Similarly, the performance measure should note the need to move beyond simple documentation of preferences for specific decisions, such as DNR, hospitalization, and document more general values and preferences, such as whether qualify of life or longevity is more important. As recently described by Sudore and Fried (and discussed on GeriPal), new paradigms of end of life decision making focus less on documentation of specific preferences, and more on preparing caregivers for in the moment decision making.
All in all, these performance measures have the potential to improve care for patients with dementia. It is laudable that the developers are seeking comment, and GeriPalers could have a positive impact by weighing in with their thoughts.

by: Ken Covinsky


Popular posts from this blog

Lost in Translation: Google’s Translation of Palliative Care to ‘Do-Nothing Care’

by: Cynthia X. Pan, MD, FACP, AGSF (@Cxpan5X)

My colleagues often ask me: “Why are Chinese patients so resistant to hospice and palliative care?” “Why are they so unrealistic?” “Don’t they understand that death is part of life?” “Is it true that with Chinese patients you cannot discuss advance directives?”

As a Chinese speaking geriatrician and palliative care physician practicing in Flushing, NY, I have cared for countless Chinese patients with serious illnesses or at end of life.  Invariably, when Chinese patients or families see me, they ask me if I speak Chinese. When I reply “I do” in Mandarin, the relief and instant trust I see on their faces make my day meaningful and worthwhile.

At my hospital, the patient population is about 30% Asian, with the majority of these being Chinese. Most of these patients require language interpretation.  It becomes an interesting challenge and opportunity, as we often need to discuss advance directives, goals of care, and end of life care options…

Elderhood: Podcast with Louise Aronson

In this week's podcast we talk with Louise Aronson MD, MFA, Professor of Geriatrics at UCSF about her new book Elderhood, available for purchase now for delivery on the release date June 11th.

We are one of the first to interview Louise, as she has interviews scheduled with other lesser media outlets to follow (CBS This Morning and Fresh Air with Terry...somebody).

This book is tremendously rich, covering a history of aging/geriatrics, Louise's own journey as a geriatrician facing burnout, aging and death of family of Louise's members, insightful stories of patients, and more.

We focus therefore on the 3 main things we think our listeners and readers will be interested in.

First - why the word "Elder" and "Elderhood" when JAGS/AGS and others recently decided that the preferred terminology was "older adult"?

Second - Robert Butler coined the term ageism in 1969 - where do we see ageism in contemporary writing/thinking?  We focus on Louise's…

Psychedelics: Podcast with Ira Byock

In this week's podcast, we talk with Dr. Ira Byock, a leading palliative care physician, author, and public advocate for improving care through the end of life.

Ira Byock wrote a provocative and compelling paper in the Journal of Pain and Symptom Management titled, "Taking Psychedelics Seriously."

In this podcast we challenge Ira Byock about the use of psychedelics for patients with serious and life-limiting illness.   Guest host Josh Biddle (UCSF Palliative care fellow) asks, "Should clinicians who prescribe psychedelics try them first to understand what their patient's are going through?" The answer is "yes" -- read or listen on for more!

While you're reading, I'll just go over and lick this toad.


You can also find us on Youtube!

Listen to GeriPal Podcasts on:
iTunes Google Play MusicSoundcloudStitcher
Eric: Welcome to the GeriPal Podcast. This is Eric Widera.

Alex: This is Alex Smith.

Eric: Alex, I spy someone in our …